Immatics (IMTX) Stock Forecast, Price Target & Predictions
IMTX Stock Forecast
Immatics stock forecast is as follows: an average price target of $22.00 (represents a 190.24% upside from IMTX’s last price of $7.58) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
IMTX Price Target
IMTX Analyst Ratings
Buy
Immatics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 16, 2024 | Graig Suvannavejh | Mizuho Securities | - | - | 44.40% | 111.08% |
Aug 09, 2022 | Geulah Livshits | Chardan Capital | - | - | 125.26% | 269.39% |
10
Immatics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $16.00 |
Last Closing Price | $7.58 | $7.58 | $7.58 |
Upside/Downside | -100.00% | -100.00% | 111.08% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 18, 2024 | Bank of America Securities | Buy | Buy | Hold |
Oct 07, 2024 | Piper Sandler | Overweight | Initialise |
10
Immatics Financial Forecast
Immatics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | $9.80M | $37.65M | $15.06M | $17.21M | $102.91M | $15.73M | $6.44M | $5.19M | $7.40M | $9.45M | $6.90M |
Avg Forecast | $14.43M | $14.43M | $18.32M | $17.89M | $15.08M | $15.86M | $13.40M | $20.53M | $13.83M | $10.92M | $20.43M | $11.91M | $23.55M | $162.16M | $10.27M | $10.79M | $8.83M | $8.59M | $7.83M | $7.30M | $5.75M | $6.36M |
High Forecast | $14.43M | $14.43M | $18.32M | $17.89M | $15.08M | $19.85M | $13.84M | $21.28M | $21.17M | $11.10M | $20.43M | $11.91M | $23.55M | $162.16M | $10.27M | $10.79M | $8.83M | $8.59M | $7.83M | $7.30M | $5.75M | $7.65M |
Low Forecast | $14.43M | $14.43M | $18.32M | $17.89M | $15.08M | $12.49M | $12.95M | $19.78M | $6.49M | $10.73M | $20.43M | $11.91M | $23.55M | $162.16M | $10.27M | $10.79M | $8.83M | $8.59M | $7.83M | $7.30M | $5.75M | $4.07M |
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.82% | 1.60% | 0.09% | 1.68% | 9.54% | 1.78% | 0.75% | 0.66% | 1.01% | 1.64% | 1.08% |
Forecast
Immatics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | $-22.36M | $10.46M | $-19.44M | $-14.82M | $70.13M | $-15.33M | $-25.34M | $-22.50M | $-20.40M | $-21.53M | $-17.64M |
Avg Forecast | $-10.71M | $-10.71M | $-13.60M | $-13.27M | $-11.19M | $-11.77M | $-9.94M | $-15.24M | $-10.26M | $-8.10M | $-15.16M | $-8.84M | $-17.48M | $-121.03M | $-7.66M | $-8.05M | $-6.59M | $-6.41M | $-5.84M | $-5.45M | $-4.29M | $-4.75M |
High Forecast | $-10.71M | $-10.71M | $-13.60M | $-13.27M | $-11.19M | $-9.27M | $-9.61M | $-14.68M | $-4.82M | $-7.96M | $-15.16M | $-8.84M | $-17.48M | $-121.03M | $-7.66M | $-8.05M | $-6.59M | $-6.41M | $-5.84M | $-5.45M | $-4.29M | $-3.04M |
Low Forecast | $-10.71M | $-10.71M | $-13.60M | $-13.27M | $-11.19M | $-14.73M | $-10.27M | $-15.79M | $-15.71M | $-8.24M | $-15.16M | $-8.84M | $-17.48M | $-121.03M | $-7.66M | $-8.05M | $-6.59M | $-6.41M | $-5.84M | $-5.45M | $-4.29M | $-5.71M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 2.53% | -0.60% | 0.16% | 1.93% | -8.71% | 2.33% | 3.96% | 3.85% | 3.74% | 5.02% | 3.72% |
Forecast
Immatics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | $-15.12M | $-13.26M | $-20.93M | $-13.98M | $85.66M | $-17.51M | $-31.41M | $-24.23M | $-19.36M | $-25.15M | $-22.77M |
Avg Forecast | $-30.60M | $-30.60M | $-27.54M | $-25.50M | $-32.35M | $-26.51M | $-29.87M | $-21.73M | $-34.00M | $-38.42M | $-26.08M | $-28.70M | $-7.92M | $206.11M | $-39.19M | $-32.61M | $-35.85M | $-32.87M | $-33.21M | $-26.96M | $-16.38M | $-15.57M |
High Forecast | $-30.60M | $-30.60M | $-27.54M | $-25.50M | $-32.35M | $-21.60M | $-29.87M | $-21.73M | $-27.36M | $-38.42M | $-26.08M | $-28.70M | $-7.92M | $206.11M | $-39.19M | $-32.61M | $-35.85M | $-32.87M | $-33.21M | $-26.96M | $-16.38M | $-13.74M |
Low Forecast | $-30.60M | $-30.60M | $-27.54M | $-25.50M | $-32.35M | $-36.33M | $-29.87M | $-21.73M | $-39.80M | $-38.42M | $-26.08M | $-28.70M | $-7.92M | $206.11M | $-39.19M | $-32.61M | $-35.85M | $-32.87M | $-33.21M | $-26.96M | $-16.38M | $-19.23M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 1.68% | -0.10% | 0.36% | -2.63% | 0.49% | 0.96% | 0.73% | 0.72% | 1.54% | 1.46% |
Forecast
Immatics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | $9.59M | $9.74M | $8.42M | $8.68M | $9.28M | $8.84M | $8.27M | $8.27M | $8.43M | $8.70M | $10.08M |
Avg Forecast | $10.45M | $10.45M | $13.27M | $12.95M | $10.92M | $11.48M | $9.70M | $14.86M | $10.01M | $7.90M | $14.79M | $8.62M | $17.05M | $117.40M | $7.43M | $7.81M | $6.39M | $6.22M | $5.67M | $5.29M | $4.16M | $4.61M |
High Forecast | $10.45M | $10.45M | $13.27M | $12.95M | $10.92M | $14.37M | $10.02M | $15.41M | $15.33M | $8.04M | $14.79M | $8.62M | $17.05M | $117.40M | $7.43M | $7.81M | $6.39M | $6.22M | $5.67M | $5.29M | $4.16M | $5.54M |
Low Forecast | $10.45M | $10.45M | $13.27M | $12.95M | $10.92M | $9.04M | $9.38M | $14.32M | $4.70M | $7.77M | $14.79M | $8.62M | $17.05M | $117.40M | $7.43M | $7.81M | $6.39M | $6.22M | $5.67M | $5.29M | $4.16M | $2.95M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 0.57% | 0.07% | 1.17% | 1.19% | 1.38% | 1.33% | 1.46% | 1.60% | 2.09% | 2.19% |
Forecast
Immatics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | $-0.20 | $-0.20 | $-0.32 | $-0.22 | $1.36 | $-0.28 | $-0.50 | $-0.39 | $-0.31 | $-0.40 | $-0.36 |
Avg Forecast | $-0.29 | $-0.29 | $-0.26 | $-0.24 | $-0.31 | $-0.25 | $-0.28 | $-0.20 | $-0.32 | $-0.36 | $-0.25 | $-0.27 | $-0.07 | $2.00 | $-0.38 | $-0.32 | $-0.35 | $-0.32 | $-0.32 | $-0.26 | $-0.16 | $-0.15 |
High Forecast | $-0.29 | $-0.29 | $-0.26 | $-0.24 | $-0.31 | $-0.20 | $-0.28 | $-0.20 | $-0.26 | $-0.36 | $-0.25 | $-0.27 | $-0.07 | $2.00 | $-0.38 | $-0.32 | $-0.35 | $-0.32 | $-0.32 | $-0.26 | $-0.16 | $-0.13 |
Low Forecast | $-0.29 | $-0.29 | $-0.26 | $-0.24 | $-0.31 | $-0.34 | $-0.28 | $-0.20 | $-0.38 | $-0.36 | $-0.25 | $-0.27 | $-0.07 | $2.00 | $-0.38 | $-0.32 | $-0.35 | $-0.32 | $-0.32 | $-0.26 | $-0.16 | $-0.19 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.74% | 2.68% | -0.16% | 0.58% | -4.30% | 0.81% | 1.57% | 1.21% | 1.18% | 2.52% | 2.38% |
Forecast
Immatics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ALXO | ALX Oncology | - | - | 1799.22% | Buy |
LYEL | Lyell Immunopharma | - | - | 625.00% | Hold |
AVTE | Aerovate Therapeutics | - | - | 398.08% | Hold |
BCAB | BioAtla | - | - | 259.71% | Buy |
FENC | Fennec Pharmaceuticals | - | - | 233.69% | Buy |
IMTX | Immatics | - | - | 190.24% | Buy |
MLYS | Mineralys Therapeutics | - | - | 152.74% | Buy |
SNDX | Syndax Pharmaceuticals | - | - | 119.87% | Buy |
REPL | Replimune Group | - | - | 119.00% | Buy |
KROS | Keros Therapeutics | - | - | 90.56% | Buy |
KRON | Kronos Bio | - | - | 87.36% | Buy |
MRUS | Merus | - | - | 72.84% | Buy |
HRMY | Harmony Biosciences | - | - | 47.04% | Buy |
EWTX | Edgewise Therapeutics | - | - | 40.71% | Buy |
JANX | Janux Therapeutics | - | - | 31.61% | Buy |
CRNX | Crinetics Pharmaceuticals | - | - | 22.99% | Buy |